Logo image of SFUN

FANG HOLDINGS LTD - ADR (SFUN) Stock Fundamental Analysis

NYSE:SFUN - New York Stock Exchange, Inc. - US30711Y3009 - ADR

2.8  -0.22 (-7.28%)

Fundamental Rating

1

Taking everything into account, SFUN scores 1 out of 10 in our fundamental rating. SFUN was compared to 71 industry peers in the Interactive Media & Services industry. SFUN has a bad profitability rating. Also its financial health evaluation is rather negative. SFUN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SFUN has reported negative net income.
SFUN Yearly Net Income VS EBIT VS OCF VS FCFSFUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 100M -100M -200M

1.2 Ratios

Industry RankSector Rank
ROA -0.45%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SFUN Yearly ROA, ROE, ROICSFUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 -10 -20 -30

1.3 Margins

Industry RankSector Rank
OM 14.08%
PM (TTM) -3.97%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SFUN Yearly Profit, Operating, Gross MarginsSFUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 20 -20 40 -40 60 80

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, SFUN has more shares outstanding
The debt/assets ratio for SFUN has been reduced compared to a year ago.
SFUN Yearly Shares OutstandingSFUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 20M 40M 60M 80M
SFUN Yearly Total Debt VS Total AssetsSFUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 0.54, we must say that SFUN is in the distress zone and has some risk of bankruptcy.
SFUN has a Debt/Equity ratio of 0.59. This is a neutral value indicating SFUN is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 0.54
ROIC/WACCN/A
WACCN/A
SFUN Yearly LT Debt VS Equity VS FCFSFUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 200M -200M 400M 600M 800M

2.3 Liquidity

SFUN has a Current Ratio of 1.14. This is a normal value and indicates that SFUN is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.14 indicates that SFUN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.14
SFUN Yearly Current Assets VS Current LiabilitesSFUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 500M 1B 1.5B

More info and screens

3

3. Growth

3.1 Past

SFUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -256.30%.
The earnings per share for SFUN have been decreasing by -28.25% on average. This is quite bad
Looking at the last year, SFUN shows a decrease in Revenue. The Revenue has decreased by -1.77% in the last year.
The Revenue for SFUN have been decreasing by -24.54% on average. This is quite bad
EPS 1Y (TTM)-256.3%
EPS 3YN/A
EPS 5Y-28.25%
EPS Q2Q%99.68%
Revenue 1Y (TTM)-1.77%
Revenue growth 3Y-18.23%
Revenue growth 5Y-24.54%
Sales Q2Q%13.93%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 35.08% on average over the next years. This is a very strong growth
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year104.55%
Revenue Next 2Y35.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SFUN Yearly Revenue VS EstimatesSFUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M
SFUN Yearly EPS VS EstimatesSFUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 0 10 -10 20 30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SFUN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SFUN Price Earnings VS Forward Price EarningsSFUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.63
SFUN Per share dataSFUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SFUN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

FANG HOLDINGS LTD - ADR

NYSE:SFUN (5/17/2022, 8:04:00 PM)

2.8

-0.22 (-7.28%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)05-02 2022-05-02/bmo
Earnings (Next)06-03 2022-06-03/bmo
Inst Owners0%
Inst Owner Change-50%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap252.14M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.17
P/FCF N/A
P/OCF N/A
P/B 0.38
P/tB N/A
EV/EBITDA 7.63
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.4
BVpS7.39
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.45%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 14.08%
PM (TTM) -3.97%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.14
Altman-Z 0.54
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-256.3%
EPS 3YN/A
EPS 5Y-28.25%
EPS Q2Q%99.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.77%
Revenue growth 3Y-18.23%
Revenue growth 5Y-24.54%
Sales Q2Q%13.93%
Revenue Next Year104.55%
Revenue Next 2Y35.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A